Revolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes

Abstract

Brain disorders represent a significant challenge in medical science due to the formidable blood‐brain barrier (BBB), which severely limits the penetration of conventional therapeutics, hindering effective treatment strategies. This review delves into the innovative realm of biomimetic nanodelivery systems, including stem cell‐derived nanoghosts, tumor cell membrane‐coated nanoparticles, and erythrocyte membrane‐based carriers, highlighting their potential to circumvent the BBB's restrictions. By mimicking native cell properties, these nanocarriers emerge as a promising solution for enhancing drug delivery to the brain, offering a strategic advantage in overcoming the barrier's selective permeability. We evaluate the unique benefits of leveraging cell membranes from various sources and examine advanced technologies for fabricating cell membrane‐encapsulated nanoparticles capable of masquerading as endogenous cells. This enables the targeted delivery of a broad spectrum of therapeutic agents, ranging from small molecule drugs to proteins, thereby providing an innovative approach to neurocare. Furthermore, the review contrasts the capabilities and limitations of these biomimetic nanocarriers with traditional delivery methods, underlining their potential to enable targeted, sustained, and minimally invasive treatment modalities. We conclude with a perspective on the clinical translation of these biomimetic systems, underscoring their transformative impact on the therapeutic landscape for intractable brain diseases.This article is protected by copyright. All rights reserved

Erythrocyte-Mimicking Nanovesicle Targeting Porphyromonas gingivalis for Periodontitis

“…38,39 The RBCbased drug delivery system has a long circulation time, excellent biocompatibility, and translational application prospects. 32,34,40,41 Based on the fact that P. gingivalis has a tendency to adhere to erythrocytes and acquire heme to sustain its growth and virulence (Figure 2D), a liposome containing an RBCs membrane was constructed to target P. gingivalis and deliver gallium porphyrin. Since P. gingivalis cannot distinguish between iron ions and gallium ions (Figure 2E), gallium porphyrins could be absorbed instead of iron porphyrins, thereby affecting the metabolism of P. gingivalis.…”

“…At present, many studies have shown the advantages of cell membrane-associated nanomaterials in drug delivery. , The RBC-based drug delivery system has a long circulation time, excellent biocompatibility, and translational application prospects. ,,, Based on the fact that P. gingivalis has a tendency to adhere to erythrocytes and acquire heme to sustain its growth and virulence (Figure D), a liposome containing an RBCs membrane was constructed to target P.…”

Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis

“…The utilization of naturally occurring nanoparticles within biological systems has been employed to create novel structures that enhance the development of delivery systems through the utilization of inherent targeting capabilities. 162 Biomimetic systems have demonstrated considerable utility in the field of biomedicine, namely in applications like as drug delivery, gene transport, theranostics, and biosensing. This is mostly due to their exceptional biocompatibility, little toxicity, and notable interactive properties.…”